Last reviewed · How we verify

NCT06137404

A Comparison of Metacarpophalangeal Joint Blocking Splint With Relative Motion Extension Splint for Trigger Finger

ENROLLING BY INVITATION NA Last updated 1 April 2025
What this trial tests

NA trial testing Splint in Trigger Finger in 30 participants. Enrolling by invitation.

Timeline
1 March 2022
Primary endpoint
31 March 2026
31 March 2028

Quick facts

Lead sponsorWaikato Hospital
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingtriple
Primary purposetreatment
Enrollment30
Start date1 March 2022
Primary completion31 March 2026
Estimated completion31 March 2028
Sites1 location across New Zealand

Drugs / interventions tested

Conditions studied

Sponsor

Waikato Hospital

Who can join

Eligibility, any sex, with Trigger Finger. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to evaluate the effectiveness of two splint designs in conservative management of trigger finger.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Splint

Trials testing the same drug.

Other recruiting trials for Trigger Finger

Currently open trials in the same condition.

Other Waikato Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06137404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing